🟢 Cardio Diagnostics Holdings is trading 7% up in pre-market with no clear company-specific catalyst

Cardio Diagnostics Holdings is trading at $2.01, up +6.91%, with no clear company-specific catalyst identified for its October 9 pre-market rise.

• A market report showed no headlines for October 9.
• The latest surfaced company announcement was an August 26 rural cardiovascular-care report, not a new overnight catalyst.
• The supplied backdrop is mixed: Nasdaq rose 0.80% and the S&P 500 0.41%, while recent risk-off pressure and elevated yields offer no clear direct explanation.